Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Collier

Showing results (401-410 of 508) with videos related to

Pageof 51
Sort By:
AIDS and Behavior|June 23, 2012
Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIVDoyle E Patton, Steven Paul Woods, Donald Franklin, et al.
The Lancet. Digital Health|September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trialRobert Gross, Justin Ritz, Michael D Hughes, et al.
Journal of Virology|February 12, 2010
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotypeWarren L Dinges, Julia Richardt, David Friedrich, et al.
The Journal of Clinical Investigation|June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiationJaimy Joy, Ana Gervassi, Lennie Chen, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
Annals of Neurology|December 11, 2008
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathyRonald J Ellis, Jennifer Marquie-Beck, Patrick Delaney, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
Neurology|December 16, 2014
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected peopleDavid B Clifford, Florin Vaida, Yu-Ting Kao, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infectionLinda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
Pageof 51

Showing results (401-410 of 508) with videos related to

Sort By:
Pageof 51
AIDS and Behavior|June 23, 2012
Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIVDoyle E Patton, Steven Paul Woods, Donald Franklin, et al.
The Lancet. Digital Health|September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trialRobert Gross, Justin Ritz, Michael D Hughes, et al.
Journal of Virology|February 12, 2010
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotypeWarren L Dinges, Julia Richardt, David Friedrich, et al.
The Journal of Clinical Investigation|June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiationJaimy Joy, Ana Gervassi, Lennie Chen, et al.
AIDS (London, England)|November 24, 1999
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance ProgramD Brambilla, P S Reichelderfer, J W Bremer, et al.
Annals of Neurology|December 11, 2008
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathyRonald J Ellis, Jennifer Marquie-Beck, Patrick Delaney, et al.
Annals of Internal Medicine|October 15, 1993
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infectionA C Collier, R W Coombs, M A Fischl, et al.
Neurology|December 16, 2014
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected peopleDavid B Clifford, Florin Vaida, Yu-Ting Kao, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infectionLinda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
Pageof 51